Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.48 |
| ▸ | NOS1 | P29475 | 1/20 | 0.48 |
| ▸ | NOS2 | P35228 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 3/20 | 0.43 |
| ▸ | HTR2B | P41595 | 3/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | ATR | Q13535 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23736440 | 0.93 | SMN1; SMN2 (0.44) | NOS3NOS1NOS2CHRM2CHRM4 | |
| SCHEMBL31309223 | 0.81 | LTA4H (0.47) | NOS3NOS1NOS2 | |
| SCHEMBL15651062 | 0.78 | NOS3 (0.52) | NOS3NOS1NOS2HTR2CHTR2B | |
| SCHEMBL21238938 | 0.78 | CYP11B1 (0.42) | NOS3NOS1NOS2HTR2CHTR2B | |
| SCHEMBL9117247 | 0.78 | PDE4A (0.49) | NOS3NOS1NOS2 | |
| SCHEMBL31234741 | 0.78 | NAMPT (0.44) | — | |
| SCHEMBL30541530 | 0.77 | SCD (0.43) | HTR2CHTR2B | |
| SCHEMBL13161940 | 0.76 | CHRM4 (0.43) | NOS3NOS1NOS2HTR2CHTR2B | |
| SCHEMBL7470506 | 0.75 | NOS3 (0.42) | NOS3NOS1NOS2HTR2CHTR2B | |
| SCHEMBL23609421 | 0.75 | SSTR4 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116583283-A | CDK inhibitors and their use as pharmaceuticals | 普莱鲁德疗法有限公司 | 2023-08-11 | — | — | CN | disclosed |